AI summary · may contain errors
An EDTA-enhanced NANDA DBS workflow with a 100 mM EDTA wash enables single-shot identification of more than 7,000 proteins from dried blood spots using Orbitrap Astral.
- Open access
Moving in Annals of the Rheumatic Diseases, Gastroenterology, bioRxiv, JAMA Oncology, medRxiv, Nature Communications, Nature Reviews Drug Discovery and Trends in Biotechnology.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
An EDTA-enhanced NANDA DBS workflow with a 100 mM EDTA wash enables single-shot identification of more than 7,000 proteins from dried blood spots using Orbitrap Astral.
AI summary · may contain errors
A forward-looking NAM framework is proposed to adapt mathematically modeled, AI, organ-on-a-chip, and advanced in vitro/ex vivo tools for predicting immunogenicity risks of gene therapies, cell treatments, and gene editors.
AI summary · may contain errors
Downstream purification of next-generation biotherapeutics requires modality-specific separation strategies, because their structural and physicochemical differences create distinct manufacturing challenges beyond mAb expertise.
AI summary · may contain errors
EPO fused to the albumin variant QMP shows 5.2-fold prolonged plasma half-life in human FcRn–expressing mice versus EPO fused to WT albumin after intravenous dosing.
AI summary · may contain errors
Biosimilar entry for bevacizumab, rituximab, and trastuzumab in US oncology is linked to a 3.8% annual ASP decline and falling reference market share.
AI summary · may contain errors
In a retrospective single-center cohort of 98 Crohn’s disease patients in Milan, FAMD clustering identified three disease-course trajectory phenotypes, including a small high-burden C3 group (n=11).
Journals this month
Topics moving, week to 17 Nov 2026
By field